Number and percentage of IL10 promoter haplotypes in the non-NP-SLE and NP-SLE patients, the combination of these groups, and controls
| Haplotype | non-NP-SLE | NP-SLE | SLE | Controls | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | ||||||||
| GCC | 61 | 61 | 34 | 40 | 95 | 52 | 178 | 55 | |||||||
| ACC | 22 | 22 | 25 | 30 | 47 | 26 | 87 | 27 | |||||||
| ATA | 17 | 17 | 25 | 30 | 42 | 23 | 59 | 18 | |||||||
n: number of haplotypes.